SLDB - Balance Sheet - Solid Biosciences Inc.

Current Liabilities	30.3 M
Accounts Payable	4.24 M
Short-Term Debt	3.02 M
Other Current Liabilities	23 M
Non-Current Liabilities	21.2 M
Long-Term Debt	0
Other Non-Current Liabilities	21.2 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018	Dec-2017	Dec-2016	Dec-2015
ASSETS
Cash & Cash Equivalents	80.2	74.0	155.4	119.1	154.7	76.0	86.4	52.1	7.7	28.6
Short Term Investments	68.7	49.6	58.3	88.6	0	7.5	36.1	17.0	30.0	26.8
Receivables	0	0	0	0.1	0	0	0	0	0	0
Inventory	0	0	0	6.0	0	0	0	0	0	0
Other Current Assets	1.7	6.1	8.8	14.7	4.2	2.8	6.2	1.6	2.3	0.3
Total Current Assets	157.3	129.7	219.6	222.6	158.9	86.3	128.6	70.7	40.0	55.7
PP&E	29.0	33.2	38.6	7.6	11.7	16.6	10.4	2.4	0.5	0
Intangible Assets	0	0	0	0	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0	0	0	0	0
Long Term Investments	0	0	1.8	2.1	0.3	0.3	0	0	0	0
Other Long Term Assets	2.3	2.0	0.2	94 K	0.2	0.2	0.5	3.1	0.2	0
Other Assets	0	0	0	0	0	0	0	0	0	0
Total Assets	188.7	164.9	260.3	232.4	171.2	103.5	139.6	76.2	40.6	55.7
LIABILITIES
Accounts Payable	4.2	2.0	3.2	4.5	3.3	7.1	3.7	5.1	3.0	0.6
Short Term Debt	3.0	2.3	5.1	3.0	4.4	3.8	0.3	0	0	0
Other Current Liabilities	23.0	10.2	14.1	8.1	6.4	7.3	8.4	6.2	3.5	13.3
Total Current Liabilities	30.3	14.5	22.5	23.6	24.5	18.3	12.5	11.3	6.9	13.9
Long Term Debt	0	23.9	52.0	1.1	5.9	10.3	1.7	0	0	0
Deferred Tax Income	0	0	0	0	0	0	0	0	0	0
Other Liabilities	0	0	(25.9)	(0.6)	(1.6)	(5.1)	0.2	0	71.6	61.7
Total Liabilities	51.4	38.5	48.6	24.2	39.1	23.4	14.4	135.4	78.5	75.6
EQUITY
Common Stock	40 K	20 K	20 K	0.1	87 K	48 K	35 K	65.0	0.6	0.2
Retained Earnings	(783.5)	(658.8)	(562.7)	(476.8)	(404.6)	(316.3)	(199.1)	(124.3)	(84.9)	(67.7)
Other Accumulative Comprehensive Income/Loss	47 K	15 K	68 K	45 K	0	1 K	5 K	13 K	23 K	10 K
Total Equity	137.2	126.5	211.7	208.2	132.1	80.0	125.2	(59.3)	(37.9)	(19.9)
Total Liabilities and Equity	188.7	164.9	260.3	232.4	171.2	103.5	139.6	76.2	40.6	55.7
SHARES OUTSTANDING
Common Shares Outstanding	40.8	19.9	8.5	7.1	3.5	2.7	2.2	2.1	1.3	1.3

Free